Metabolic Syndrome and Mortality in Continuous Ambulatory Peritoneal Dialysis Patients: A 5-Year Prospective Cohort Study
Background/Aims: Metabolic syndrome (MS) has been widely proved as a predictor of cardiovascular disease, all-cause, and cardiovascular mortality in general population. But its effects on mortality and technique failure have not been well illustrated in peritoneal dialysis (PD) patients. We aimed to...
Main Authors: | WenLong Gu, Chunyan Yi, Xueqing Yu, Xiao Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-09-01
|
Series: | Kidney & Blood Pressure Research |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/502145 |
Similar Items
-
Plasma fibrinogen and mortality in patients undergoing peritoneal dialysis: a prospective cohort study
by: Jing Yu, et al.
Published: (2020-08-01) -
Prognostic value of inflammation-based prognostic scores on outcome in patients undergoing continuous ambulatory peritoneal dialysis
by: Lu Cai, et al.
Published: (2018-10-01) -
Serum Chloride and Mortality in patients on continuous ambulatory peritoneal dialysis: A multi-center retrospective study
by: Lei Zhou, et al.
Published: (2021-11-01) -
Risk Factors and Outcomes of Early-Onset Peritonitis in Chinese Peritoneal Dialysis Patients
by: Yuanshi Tian, et al.
Published: (2017-12-01) -
Association of baseline, longitudinal serum high-sensitive C-reactive protein and its change with mortality in peritoneal dialysis patients
by: Wei Li, et al.
Published: (2017-07-01)